Santen Pharmaceutical Co Ltd's ticker is SNPHY and the CUSIP is 80287P100. A total of 5 filers reported holding Santen Pharmaceutical Co Ltd in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $44,000 | 0.0% | 2,307 | 0.0% | 0.00% | – |
| Q4 2019 | $44,000 | +4.8% | 2,307 | -4.8% | 0.00% | – |
| Q3 2019 | $42,000 | -2.3% | 2,423 | -7.1% | 0.00% | – |
| Q2 2019 | $43,000 | -4.4% | 2,609 | -14.6% | 0.00% | – |
| Q1 2019 | $45,000 | +95.7% | 3,056 | +89.1% | 0.00% | – |
| Q4 2018 | $23,000 | -4.2% | 1,616 | +6.2% | 0.00% | – |
| Q3 2018 | $24,000 | -40.0% | 1,521 | -33.6% | 0.00% | – |
| Q2 2018 | $40,000 | +37.9% | 2,291 | +20.2% | 0.00% | – |
| Q1 2018 | $29,000 | 0.0% | 1,906 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | +3.6% | 1,906 | +6.5% | 0.00% | – |
| Q3 2017 | $28,000 | +33.3% | 1,789 | +20.1% | 0.00% | – |
| Q2 2017 | $21,000 | 0.0% | 1,490 | 0.0% | 0.00% | – |
| Q1 2017 | $21,000 | +162.5% | 1,490 | +111.0% | 0.00% | – |
| Q4 2016 | $8,000 | – | 706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 411,257 | $5,030,000 | 0.01% |
| QUADRANT CAPITAL GROUP LLC | 592 | $5,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 238 | $3,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 34,842 | $427,000 | 0.00% |
| GLENMEDE TRUST CO NA | 706 | $8,000 | 0.00% |